Welcome to this course based on Scientific Impact Paper No. 66: Risk-reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause.
The scope of this guidance includes:
- use of hormone replacement therapy (HRT) post-removal of fallopian tubes and ovaries, to prevent ovarian cancer in premenopausal, high-risk women
- ovarian cancer
- endometrial cancer
- cervical cancer.
This content includes:
- an animated summary, which will take you on an illustrated journey through all the recommendations in the paper with supporting evidence
- a complete audio recording of the Scientific Impact Paper in full for those that like to listen on-the-go or are auditory learners.
Product Details:
Product Name
Price
Scientific Impact Paper No. 66: Risk-Reducing Salpingo-Oophorectomy and the use of HRT Below the Age of Natural Menopause - 12 Month Access
£25.20
Login to purchase
| Product Name | Price | |
| Scientific Impact Paper No. 66: Risk-Reducing Salpingo-Oophorectomy and the use of HRT Below the Age of Natural Menopause - 12 Month Access | £25.20 | Login to purchase |